Dexamethasone Suppression Tests in
by I C Gilliland MD FRCPEd and M B Ghose MRCP (London) A previous communication showed that the level of thyroid stimulating hormone (TSH) was raised in 15 out of 18 patients with Graves' disease (Gilliland & Strudwick 1956 ). TSH was not, however, the cause of the exophthalmos and some other factor was involved. Smelsner & Ozanics (1955) , after some careful studies of pituitary extracts with experimental animals, suggested that the additional factor was ACTH. For this reason we decided to investigate ACTH in Graves' disease. This work is still in progress.
Method
The patients studied were untreated and obvious cases of Graves' disease. Their ages ranged from 20 to 54; there were 8 women and 6 men. Not only was the diagnosis clinically obvious but hyperthyroidism was confirmed by radioactive iodine tests. The BMR varied from +40% to +90%. They had uniform thyroid involvement and had exophthalmos or ophthalmoplegia and frequently both. In 2 cases the eye signs were the presenting symptoms.
Dexamethasone was administered to suppress endogenous output of steroid metabolites; these were measured as 1 7-ketosteroids and 1 7-hydroxicorticosteroids by the method-of Moxham & Nabarro (1956) .
Dexamethasone was chosen as Jadresic et al. (1960) showed it to be the most efficient. Liddle (1960) showed that 2 mg per day for two days was sufficient to suppress hydroxicorticosteroid output to zero in normal people. The initial level employed was 3 mg a day for a week on the first 10 patients. This dose was doubled in the next 4 patients. Table 1 gives the excretion of 17-hydroxicorticosteroids before and after one week of 3 mg .00 dexamethasone per day. Table 2 shows the 17corticosteroid output after 6 mg a day.
Results

Discussion
In these patients with Graves' disease the endogenous output of corticosteroids was suppressed in only 1 of 10 patients at 3 mg a day and in 1 of 4 patients at 6 mg a day. This findingis in agreement with previous suggestions that there is an excess production of adrenal hormones in Graves' disease. Peterson et al. (1955) , using 14C-labelled steroids, showed that, although normal levels of circulating hormone were found, the clearance rates were much accelerated. This implied exces-sive steroid production with concomitant raised level of ACTH production. Hellman et al. (1961) also showed an absolute increase in the production of adrenal hormones with the inference that ACTH production is also increased. They explained the absence of some of the signs of Cushing's disease by the metabolic diversion of hydrocortisone to inactive 11-keto metabolites. These results support the inference which we draw from our data that ACTH is produced in excess in Graves' disease. This is also compatible with the suggestion that ACTH could be the other factor involved with TSH in the production of exophthalmos.
Blood ACTH in Graves' Disease [Abridged] by Beryl M A Davies Msc PhD, MB Ghose MRCP and I C Gilliland MD FRCPEd (London)
In his latest review Sayers (1961) gives no values for the level of blood corticotrophin in Graves' disease. Recently Hellman et al. (1961) have suggested that there is an increased secretion of ACTH in hyperthyroidism because of altered production and metabolism of cortisol. The present investigation was carried out on 500 ml blood from patients with Graves' disease with exophthalmos. The blood was concentrated by Sydnor & Sayers' (1952) oxycellulose adsorption-HCI elution procedure. It was bioassayed by amodificationof the methodof Sayers etal. (1948) . This involved measuring the decrease in adrenal ascorbic acid one hour after the intravenous injection of the blood concentrate, used at three dose levels, in hydrocortisone-treated rats. Responses were compared with those given with doses of 2nd International Standard for corticotrophin (Currie & Davies 1962 ). These methods have previously been used in this laboratory to estimate blood ACTH in normal and hypertensive subjects and in Cushing's syndrome (Davies et al. 1960 , Davies 1962 . The minimum quantity of normal blood in which ACTH can be detected with this bioassay is 1 litre. Values for two pools of normal blood were 0-71 milliunit/100 ml blood (3 subjects) and 0-71 milliunit/100 ml (2 subjects).
In 5 cases of Graves' disease with eye signs no ACTH could be detected in 3 of them, indicating a level of less than 1 0 milliunit/100 ml blood. In the other 2 cases, levels of 1 *62 and 5 56 milliunits/ 100 ml blood were obtained. While no conclusions can be drawn from such a small series, it will be of interest to investigate more cases and to try to correlate the blood ACTH levels with other clinical and biochemical data.
